NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Codexis Inc (NASDAQ: CDXS)

 
CDXS Technical Analysis
5
As on 9th Jun 2023 CDXS SHARE Price closed @ 2.54 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 13.10 & Strong Sell for SHORT-TERM with Stoploss of 22.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CDXSSHARE Price

Open 2.56 Change Price %
High 2.60 1 Day -0.02 -0.78
Low 2.48 1 Week 0.33 14.93
Close 2.54 1 Month -1.36 -34.87
Volume 398800 1 Year -28.02 -91.69
52 Week High 34.08 | 52 Week Low 2.21
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
CDXS
Daily Charts
CDXS
Intraday Charts
Whats New @
Bazaartrend
CDXS
Free Analysis
 
CDXS Important Levels Intraday
RESISTANCE2.77
RESISTANCE2.70
RESISTANCE2.65
RESISTANCE2.61
SUPPORT2.47
SUPPORT2.43
SUPPORT2.38
SUPPORT2.31
 
CDXS Forecast April 2024
4th UP Forecast22.43
3rd UP Forecast16.05
2nd UP Forecast12.11
1st UP Forecast8.16
1st DOWN Forecast-3.08
2nd DOWN Forecast-7.03
3rd DOWN Forecast-10.97
4th DOWN Forecast-17.35
 
CDXS Weekly Forecast
4th UP Forecast14.78
3rd UP Forecast10.85
2nd UP Forecast8.43
1st UP Forecast6.00
1st DOWN Forecast-0.92
2nd DOWN Forecast-3.35
3rd DOWN Forecast-5.77
4th DOWN Forecast-9.70
 
CDXS Forecast2024
4th UP Forecast65.05
3rd UP Forecast45
2nd UP Forecast32.61
1st UP Forecast20.22
1st DOWN Forecast-15.14
2nd DOWN Forecast-27.53
3rd DOWN Forecast-39.92
4th DOWN Forecast-59.97
 
 
CDXS Other Details
Segment EQ
Market Capital 2246264320.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CDXS Address
CDXS
 
CDXS Latest News
 
Your Comments and Response on Codexis Inc
 
CDXS Business Profile
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California. Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service